Literature DB >> 28835633

The changing epidemiological characteristics of severe fever with thrombocytopenia syndrome in China, 2011-2016.

Jimin Sun1,2, Liang Lu1, Haixia Wu1, Jun Yang1, Jiangping Ren2, Qiyong Liu3.   

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is emerging and the number of SFTS cases increased year by year in China. In order to explore the epidemiology trend, we analyzed the changing epidemiological characteristics of SFTS cases in different years and compare characteristics in different provinces. From 2011 to 2016, a total of 5360 laboratory-confirmed SFTS cases were reported and annual case numbers increased year by year. Most SFTS cases occurred in individuals aged between 40 years and 80 years (91.57%), but age distributions of SFTS cases in different years were significantly different and the median ages increased slightly year by year. The numbers of affected counties from 2011 to 2016 increased sharply from 98 to 167. Of note, the seasonal distributions of SFTS cases in different provinces were significantly different (Fisher = 712.157, P = 0.000) and provinces in south regions showed earlier epidemic peak and longer epidemics durations. The median time from illness onset to confirmation of different years was significantly different (χ2 = 896.088, P = 0.000) and it peaked in 2014. Furthermore, case fatality rate was associated with province, year, and age of SFTS cases. These results may be helpful for authorities to better preventive strategy and improve interventions against SFTS.

Entities:  

Mesh:

Year:  2017        PMID: 28835633      PMCID: PMC5569157          DOI: 10.1038/s41598-017-08042-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

In 2009, a novel virus, named severe fever with thrombocytopenia syndrome virus (SFTSV) was first identified in the rural areas of Hubei Province and Henan Province in central China[1, 2]. SFTSV is classified in the family Bunyaviridae, genus Phlebovirus and contains three segments of negative or ambisense polarity RNA, designated L, M and S segments. The virus can cause severe fever with thrombocytopenia syndrome (SFTS) and the average case fatality rate of SFTS was about 30% when this disease was firstly discovered. The clinical symptoms of SFTS include fever, fatigue, chill, headache, lymphadenopathy, anorexia, nausea, myalgia, diarrhea, vomiting, abdominal pain, gingival hemorrhage, conjunctival congestion, and so on[3]. Some SFTS patients experience self-limiting clinical course, while some patients decease due to multiple organ failure[4, 5]. Moreover, the clinical symptoms of SFTS are less specific and need to be differentiated from human anaplasmosis and hemorrhagic fever with renal syndrome caused by hantavirus[6, 7]. After the identification of SFTSV in 2009, the national guideline for prevention and control for SFTS was issued by the Chinese Ministry of Health in 2010 and SFTS patients should be reported by doctors within 24 hours of diagnosis to China Information System for Diseases Control and Prevention. Although confirmed SFTS or SFTS like patients have been reported in South Korea, Japan, United Arab Emirates, and United States, most SFTS cases were reported in China as of 2016[8-11]. In 2011–2012, 2047 cases of SFTS and 129 deaths were reported in over 206 counties of eastern and central China[12]. As the improvement of capacity for SFTSV identification in many areas, more and more SFTS patients were identified in recent years. Here, we analyze the changing epidemiological characteristics of SFTS in different years and different provinces which will provide more detailed information for the prevention of SFTS. Furthermore, factors associated with SFTS fatal outcome are also analyzed to aid the decrease of case fatality rate.

Materials and Methods

Case definition

According to the national guideline for prevention and control for SFTS issued by the Chinese Ministry of Health in 2010, SFTS cases were classified as probable or confirmed cases. An acutely ill person with acute onset of fever (≥38.0 °C) and other symptoms (e.g. gastrointestinal symptoms, bleeding), epidemiological risk factors (being a farmer or being exposed to ticks two weeks before illness onset) and laboratory data consisting of thrombocytopenia and leukocytopenia was defined as a probable case. A probable case with one or more of the following criteria: (1) detection of SFTSV RNA, (2) seroconversion or 4-fold increase in antibody titers between paired serum samples collected at least two weeks apart, and (3) isolation of SFTSV in cell culture[13] was defined as a confirmed case.

Data collection

Daily disease surveillance data on SFTS from 2011 to 2016 were obtained from the China Information System for Diseases Control and Prevention. Information of SFTS cases included gender, age, occupation, residential address, date of illness onset, date of confirmation and outcome.

Data analysis

The age distribution, gender distribution, occupation distribution, seasonal distribution and the intervals from illness onset to confirmation of SFTS cases in different years were summarized using SPSS version 20.0 (Statistical Product and Service Solutions, Chicago, IL, USA). Fisher’s exact test or Wilcoxon Rank Sum W Test were used, as appropriate, to compare the demographic characteristics, seasonal distribution and the intervals from illness onset to confirmation of SFTS cases in different years. All tests were 2-tailed and statistical significance was set at P < 0.05. Seasonal distributions of SFTS cases in different provinces were also analyzed and compared. Geographical distribution of SFTS cases in different years were plotted using ArcGIS 10.1 (ESRI, Redlands, CA, USA). Additionally, single variable analysis and multivariate analysis were conducted to identify factors associated with SFTS fatal outcome using the logistic regression method.

Results

From 2011 to 2016, a total of 5360 laboratory-confirmed cases were reported to China Information System for Diseases Control and Prevention. Annual case numbers increased year by year, with the highest recorded in 2016 (1306 cases, Fig. 1). Of the total SFTS cases, 2509 cases were male and 2851 cases were female. There were more male cases than female cases in 2011, but there were less male cases than female cases from 2012 to 2016.The male-to-female ratio of different years was not significantly different (χ2 = 9.526, P = 0.090).
Figure 1

Annual numbers and incidences of SFTS cases in China from 2011 to 2016.

Annual numbers and incidences of SFTS cases in China from 2011 to 2016. The majority of SFTS cases were farmers (87.91%, 4712/5360) and the occupation distribution of SFTS cases in different years were similar (χ2 = 15.552, P = 0.113). Most SFTS cases occurred in individuals aged between 40 years and 80 years (91.57%, Table 1). The median ages of SFTS cases from 2011 to 2016 were 61 years, 60 years, 62 years, 61 years, 63 years, and 63 years, respectively. However, age distributions of SFTS cases in different years were significantly different (Kruskal-Wallis statistic = 23.334, P = 0.000) and the median ages slightly increased from 2011 to 2016.
Table 1

Age distribution of SFTS cases in China from 2011 to 2016.

201120122013201420152016
No. of casesProportion (%)No. of casesProportion (%)No. of casesProportion (%)No. of casesProportion (%)No. of casesProportion (%)No. of casesProportion (%)
0-10.2200.0000.0050.4830.2300.00
10-20.4320.3500.0080.7750.3810.08
20-10.2250.8691.33131.26181.38201.53
30-153.25203.45202.96232.22241.84392.99
40-8919.319616.587911.6915715.1816812.8814411.03
50-11224.3014625.2216925.0025624.7626120.0231524.12
60-14331.0217029.3622833.7330829.7947436.3542232.31
70-8518.4412221.0714221.0122021.2830523.3929722.74
80-132.82183.11294.29444.26463.53685.21
Total461100579100676100103410013041001306100
Age distribution of SFTS cases in China from 2011 to 2016. During 2011–2016, 99.53% of SFTS cases were limited to 7 provinces: 2025 cases were reported in Henan Province, 1515 cases in Shandong Province, 663 cases in Hubei Province, 502 cases in Anhui Province, 260 cases in Zhejiang Province, 224 cases in Liaoning Province, and 146 cases in Jiangsu Province. Besides these 7 provinces, other provinces reported only 25 SFTS cases (Table 2). The numbers of affected provinces during 2011 and 2016 were 11, 9, 11, 10, 9, and 11, respectively. However, the numbers of affected counties increased year by year and the numbers were 98, 99, 113, 140, 153, and 167, respectively (Fig. 2).
Table 2

Seasonal distribution of SFTS cases in different provinces from 2011 to 2016.

LiaoningShandongHenanHubeiJiangsuAnhuiZhejiangOther
No.P (%)No.P (%)No.P (%)No.P (%)No.P (%)No.P (%)No.P (%)No.P (%)
January00.0000.0000.0000.0000.0000.0000.0028.00
February00.0000.0000.0000.0000.0000.0000.0014.00
March10.4510.07221.0940.6110.6851.0093.4600.00
April00.00241.5926312.998212.41106.855510.98207.6900.00
May104.4627117.9161630.4216825.423322.6011021.965721.9214.00
June3113.8437424.7240620.0513320.122617.8110520.965721.92312.00
July6830.3630420.0928113.8814021.183221.928216.375721.92520.00
August6729.9127618.241376.77588.772013.706412.772610.00416.00
September3515.631409.251577.75334.99128.22295.79124.6228.00
October125.361036.811346.62355.30117.53448.78166.1528.00
November00.00201.3290.4481.2110.6871.4051.92416.00
December00.0020.1300.0020.3000.0010.2010.3814.00
Total2241001515100202510066310014610050210026010025100

*No. = Number of cases, P (%) = Proportion (%).

Figure 2

Geographical distribution of SFTS cases in China from 2011 to 2016. These maps were created by ArcGIS software (version 10.1, ESRI Inc.; Redlands, CA, USA). Homepage of ArcGIS software was https://www.esri.com/.

Seasonal distribution of SFTS cases in different provinces from 2011 to 2016. *No. = Number of cases, P (%) = Proportion (%). Geographical distribution of SFTS cases in China from 2011 to 2016. These maps were created by ArcGIS software (version 10.1, ESRI Inc.; Redlands, CA, USA). Homepage of ArcGIS software was https://www.esri.com/. During 2011–2016, 98.00% (5253/5360) of SFTS cases were reported from April to October with a peak in May, June, and July (Fig. 3). The seasonal distributions of different years were significantly different (Fisher = 276.845, P = 0.000) and the peaks of reported SFTS cases from 2011 to 2016 occurred in July, May, June, May, May, and May, respectively. Of note, the seasonal distributions of SFTS cases in different provinces were significantly different (Fisher = 721.157, P = 0.000). SFTS cases in Liaoning Province showed shorter epidemic periods than other province (Table 2). Moreover, SFTS cases in Zhejiang Province, Hubei Province, Anhui Province, and Henan Province showed earlier peaks than those in Liaoning Province, Shandong Province and Jiangsu Province (April-October vs May-October, Table 2).
Figure 3

Seasonal distribution of SFTS cases in China from 2011 to 2016.

Seasonal distribution of SFTS cases in China from 2011 to 2016. The median time from illness onset to confirmation of SFTS cases from 2011 to 2016 were 7 days, 6 days, 6 days, 27 days, 10 days and 12 days, respectively. Notably, the median time from illness onset to confirmation of different years was significantly different (χ2 = 896.088, P = 0.000) and it peaked in 2014. A total of 343 deaths were reported in China from 2011 to 2016 and the average case fatality rate was 6.40%. According to results of single variable logistic regression analysis, there were significant differences in year, province, age and gender. As shown in Table 3, the case fatality rates of SFTS cases in different years were significantly different and it decreased from 2014 to 2016. The case fatality rates of SFTS cases in different provinces were also significantly different and the lowest fatality rate recorded in Henan. The case fatality rate significantly increased with the increase of age of SFTS cases (P = 0.000).
Table 3

Single variable analysis on factors associated with SFTS fatal outcome.

SurvivorDeathWaldPOR95% CI
Year26.3090.000
20114154618.5320.0002.4291.6223.638
2012536437.3210.0071.7581.1682.645
2013628486.5230.0111.6751.1272.488
20149538112.1850.0001.8621.3142.641
20151236681.0320.3101.2060.8411.729
2016124957
Province114.3670.000
Liaoning2081614.7680.0003.1321.7505.607
Shandong134517096.4010.0005.1013.6857.062
Hubei6184525.9260.0002.9361.9404.445
Jiangsu14150.5610.4541.4300.5613.646
Anhui478247.6950.0062.0251.2303.333
Zhejiang2283253.1330.0005.6603.5519.020
Other2322.2910.1303.1020.71613.436
Henan197649
Age59.8930.0001.5611.3951.747
0-2340
40-71518
50-118871
60-1628117
70-1252137
Gender3.7940.0511.2430.9991.547
Female2686165
Male2331178
Single variable analysis on factors associated with SFTS fatal outcome. According to results of multivariable logistic regression analysis, variables in the final equation included year, province and age. Compared with cases in 2016, odds ratio (OR) of cases death in 2011–2015 were 2.836, 2.696, 1.858, 2.271 and 1.426, respectively. Compared with cases in Henan Province, OR of cases death in Liaoning, Shandong, Hubei, Jiangsu, Anhui, Zhejiang and others were 3.212, 5.528, 3.654, 1.653, 2.516, 5.854, and 4.631, respectively. Compared with cases aged 0–39, the case fatality rate increased with the increase of age and OR was1.611 (Table 4).
Table 4

Multivariable analysis on factors associated with SFTS fatal outcome.

WaldPOR95% CI
Year38.6850.000
201124.1430.0002.8361.8714.298
201220.9410.0002.6961.7634.124
20138.9430.0031.8581.2382.787
201420.0320.0002.2711.5863.252
20153.5650.0591.4260.9872.061
Province115.1100.000
Liaoning14.9220.0003.2121.7775.806
Shandong102.0700.0005.5283.9687.703
Hubei35.8790.0003.6542.3915.584
Jiangsu1.0820.2981.6530.6414.257
Anhui12.7400.0002.5161.5164.175
Zhejiang53.3590.0005.8423.6389.382
Other4.0410.0444.6311.03920.637
Age63.9110.0001.6111.4331.810
Multivariable analysis on factors associated with SFTS fatal outcome.

Discussion

In this study, surveillance data on SFTS from 2011 to 2016 was used to investigate changing epidemiological characteristics of SFTS. We found that the number of SFTS increased year by year. Two factors may contribute the result. First, SFTSV might has been spread to more areas through humans, small mammals, ticks, or birds[14]. Therefore, people in more areas have opportunities to be infected with SFTSV and more SFTS cases occurred. Second, some physicians lacked experience of SFTS diagnosis when SFTSV was identified. Some SFTS cases were misdiagnosed and the reported cases were only the tip of the iceberg. Due to the high fatality rate, more attention have been paid by health departments and some measures have been conducted to improve the capacity of diagnosis and response to SFTS. For example, all municipal center for disease control and prevention established detection methods for SFTSV in Zhejiang Province in 2014. The improvement of diagnosis and detection capacity may influence the number of reported SFTS cases. Nevertheless, the increase number of SFTS cases inform that more cases will be reported in future which prompt the research of prevention methods for SFTSV infection including the SFTSV vaccine. Occupation distributions of SFTS cases in different years were similar and the majority of cases were farmers who lived in rural areas. As SFTSV is believed to be transmitted by Haemaphysalis longicornis ticks[15], higher tick density in rural areas and more outdoor activities of farmers may contribute to the result. Farmers are the key population for the prevention of SFTS. Although most SFTS cases aged between 40 and 80, the age distributions of cases in different years were significantly different and the median age slightly increased. These high prevalence age group are in agreement with corresponding data from other studies[16-18]. Elderly people might have decreased immune function and comorbidities with chronic diseases. If they are infected with SFTSV, they may get severe diseases. It is thereby that more elderly cases were identified. Ding et al. also reported that people at all age groups were susceptible to SFTSV, but only old people got severe disease and needed to be hospitalized or even died of SFTSV infection[19]. Besides this factor, demographic features of residents in areas where SFTS cases occurred may also influence the age distribution. Generally, young adults in rural areas go to cities to earn money and then return to their hometown for the spring festival. As a result, the majority of residents of rural areas between the months of March and November are elderly people. Furthermore, high prevalence of SFTSV among elderly people indicate that SFTSV is a new virus and the immunity rate is not very high among them. SFTSV was firstly identified in Henan and Hubei, then it was identified in Anhui, Shandong, Jiangsu, Zhejiang, and Liaoning. Up to date, the overwhelming majority of SFTS cases were reported in these 7 provinces which all locate in the central part of China. We speculate that the weather in these 7 provinces is more suitable for the survival and breeding of ticks, and the transmission of SFTSV. But further study is needed to study the relation between meteorological factors and SFTSV incidence. Another factor may all influence the geographical distribution. More attentions have been paid, and more researches have been done in these 7 provinces where the capacity of SFTSV detection is developed. Although the number of affected province in different years were similar, the number of affected counties increased sharply every year and SFTS cases were also reported in other provinces besides its endemic areas. These results highlight that the fact that the geographic range of SFTSV has apparently expanded in China, which is valuable information for consideration in national planning on SFTS control and prevention. More investigation should be conducted to confirm whether SFTS is endemic in the provinces where sporadic cases were reported. Most SFTS cases occurred from April to October, but the seasonal distributions of different provinces were significantly different. Provinces in south regions showed earlier epidemic peak and longer epidemics durations. These are also related to the climate of these provinces. These results suggest that control measures should be conducted during different periods in different provinces. To our great disappointment, the interval from illness onset to confirmation from 2011 to 2016 were not shortened. These were consistent with corresponding results of another study[20]. This may be due to SFTS patients’ low incomes and poor access to medical care because most of them were from rural areas. Rural residents commonly visit local hospitals or outpatient clinics in villages or towns. These hospitals do not have the capability to identify and cure SFTSV infection. They have to go to urban areas for hospitals with better facilities for further care. The majority of hospitals don’t have the capacity to detect SFTSV and most samples are transported to municipal centers for disease control and prevention (CDC) or provincial CDC for testing. These factors prolong the interval from illness onset to confirmation. However, the interval from illness onset to confirmation is very important for the cure of SFTS cases. Sun et al. reported that an increase in interval from illness onset to confirmation by 3 days was associated with fatality with an OR of 1.996[21]. These inform that detection capability of SFTSV should be established not only in centers for diseases control and prevention but also in different hospitals to decrease the case fatality rate. The fatality rate decreased from 2011 to 2016, but it remained very high in 2016. In the analysis of factors associated with SFTS fatal outcome, fatality rates of cases in different years and different provinces were significantly different. Provinces with higher number of SFTS cases showed lower fatality rate. For example, Henan presented the highest number of SFTS cases and the lowest fatality rate. One reason is that physicians in these provinces are more experienced to cure SFTS, so cases are more probable to be cured in these provinces. Another reason is that the detection capability is developed in these provinces. Not only severe cases but also mild cases are identified in these provinces. As a result, more cases were identified and fatality rates were low in these provinces. The high fatality rate suggest that it is urgent to study effective treatments for SFTS. Previously studies have reported that case fatality rate of SFTS increases with age[10, 22–24]. Our study also indicated that age was related to the fatality rate. Some factors associated with age including decreased immune function and comorbidities with chronic diseases may be relative to SFTS fatal outcome. Nevertheless, our findings further suggest that more intense treatment should be administered to elderly SFTS cases when they were hospitalized. According to our results, we suggest that some measures should be done to prevent and control SFTS. First, health education should be enhanced. People should avoid go to hilly areas where ticks exist in epidemic seasons. If they have to go to these areas, they should dress light color clothes and check whether ticks bite them when they leave these areas. Second, hospitals in SFTS endemic areas should improve capacity of SFTSV detection. This is helpful for the early diagnosis and the decrease of fatality of SFTS patients. Finally, some measures should be conducted to decrease tick density in endemic areas during epidemic seasons. There are several limitations in our study. First, the data used were collected from China Information System for Diseases Control and Prevention which is passive surveillance. Some factors including detection capability, reporting methods, availability of health facilities may influence the data quality. Second, there are too many floating population in some provinces of China. They go to urban areas and come back hometowns irregularly. So we can’t get the real number of people who lived in rural areas during high risk seasons which is disadvantageous to analyze incidence of SFTS among people with different demographic characteristic. To the best of our knowledge, this is the first report on the changing epidemiological characteristics of SFTS in China. We found that the number of SFTS cases increased, the affected areas expanded and some demographic characteristics changed year by year indicating that surveillance and control strategies should be adjusted to account for these changes. Unfortunately, surveillance and control strategies are largely inadequate in China. For example, there are no national sentinel vector surveillance project for ticks and no national control program for ticks in China. Therefore, it is essential for China to put more effort into ticks surveillance and control. The increased interval from illness onset to confirmation further suggests that it is urgent to improve the diagnosis capability of physicians for early diagnosis. More researches should be conducted and more attention should be paid to respond the changed characteristics of SFTS.
  22 in total

1.  [Epidemiological analysis on severe fever with thrombocytopenia syndrome under the national surveillance data from 2011 to 2014, China].

Authors:  Yu Li; Hang Zhou; Di Mu; Wenwu Yin; Hongjie Yu
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2015-06

2.  Epidemiologic features of severe fever with thrombocytopenia syndrome in China, 2011-2012.

Authors:  Fan Ding; Wenyi Zhang; Liya Wang; Wenbiao Hu; Ricardo J Soares Magalhaes; Hailong Sun; Hang Zhou; Sha Sha; Shenlong Li; Qiyong Liu; Qun Li; Weizhong Yang; Liuyu Huang; Chengyi Li; Wenwu Yin
Journal:  Clin Infect Dis       Date:  2013-02-19       Impact factor: 9.079

3.  Nosocomial transmission of human granulocytic anaplasmosis in China.

Authors:  Lijuan Zhang; Yan Liu; Daxin Ni; Qun Li; Yanlin Yu; Xue-jie Yu; Kanglin Wan; Dexin Li; Guodong Liang; Xiugao Jiang; Huaiqi Jing; Jing Run; Mingchun Luan; Xiuping Fu; Jingshan Zhang; Weizhong Yang; Yu Wang; J Stephen Dumler; Zijian Feng; Jun Ren; Jianguo Xu
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

4.  Epidemiological characteristics of severe fever with thrombocytopenia syndrome in Zhejiang Province, China.

Authors:  Jimin Sun; Chengliang Chai; Huakun Lv; Junfen Lin; Chengwei Wang; Enfu Chen; Yanjun Zhang; Zhiping Chen; Shelan Liu; Zhenyu Gong; Jianmin Jiang
Journal:  Int J Infect Dis       Date:  2014-06-16       Impact factor: 3.623

5.  Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus.

Authors:  Bianli Xu; Licheng Liu; Xueyong Huang; Hong Ma; Yuan Zhang; Yanhua Du; Pengzhi Wang; Xiaoyan Tang; Haifeng Wang; Kai Kang; Shiqiang Zhang; Guohua Zhao; Weili Wu; Yinhui Yang; Haomin Chen; Feng Mu; Weijun Chen
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

6.  Hantavirus infections in humans and animals, China.

Authors:  Yong-Zhen Zhang; Yang Zou; Zhen F Fu; Alexander Plyusnin
Journal:  Emerg Infect Dis       Date:  2010-08       Impact factor: 6.883

7.  Epidemiologic features and environmental risk factors of severe fever with thrombocytopenia syndrome, Xinyang, China.

Authors:  Kun Liu; Ning Cui; Li-Qun Fang; Bing-Jun Wang; Qing-Bin Lu; Wei Peng; Hao Li; Li-Yuan Wang; Song Liang; Hong-Yu Wang; Yao-Yun Zhang; Lu Zhuang; Hong Yang; Gregory C Gray; Sake J de Vlas; Wei Liu; Wu-Chun Cao
Journal:  PLoS Negl Trop Dis       Date:  2014-05-08

8.  Phylogeographic analysis of severe fever with thrombocytopenia syndrome virus from Zhoushan Islands, China: implication for transmission across the ocean.

Authors:  Yongfeng Fu; Shibo Li; Zhao Zhang; Suqin Man; Xueping Li; Wenhong Zhang; Chiyu Zhang; Xunjia Cheng
Journal:  Sci Rep       Date:  2016-01-25       Impact factor: 4.379

9.  Factors associated with Severe Fever with Thrombocytopenia Syndrome infection and fatal outcome.

Authors:  Jimin Sun; Zhenyu Gong; Feng Ling; Rong Zhang; Zhendong Tong; Yue Chang; Enfu Chen; Qiyong Liu; Junfen Lin; Zhiping Chen; Jianmin Jiang
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

10.  The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan.

Authors:  Toru Takahashi; Ken Maeda; Tadaki Suzuki; Aki Ishido; Toru Shigeoka; Takayuki Tominaga; Toshiaki Kamei; Masahiro Honda; Daisuke Ninomiya; Takenori Sakai; Takanori Senba; Shozo Kaneyuki; Shota Sakaguchi; Akira Satoh; Takanori Hosokawa; Yojiro Kawabe; Shintaro Kurihara; Koichi Izumikawa; Shigeru Kohno; Taichi Azuma; Koichiro Suemori; Masaki Yasukawa; Tetsuya Mizutani; Tsutomu Omatsu; Yukie Katayama; Masaharu Miyahara; Masahito Ijuin; Kazuko Doi; Masaru Okuda; Kazunori Umeki; Tomoya Saito; Kazuko Fukushima; Kensuke Nakajima; Tomoki Yoshikawa; Hideki Tani; Shuetsu Fukushi; Aiko Fukuma; Momoko Ogata; Masayuki Shimojima; Noriko Nakajima; Noriyo Nagata; Harutaka Katano; Hitomi Fukumoto; Yuko Sato; Hideki Hasegawa; Takuya Yamagishi; Kazunori Oishi; Ichiro Kurane; Shigeru Morikawa; Masayuki Saijo
Journal:  J Infect Dis       Date:  2013-11-14       Impact factor: 5.226

View more
  24 in total

1.  Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus (SFTSV) in South Korea.

Authors:  Seok-Min Yun; Su-Jin Park; Young-Il Kim; Sun-Whan Park; Min-Ah Yu; Hyeok-Il Kwon; Eun-Ha Kim; Kwang-Min Yu; Hye Won Jeong; Jungsang Ryou; Won-Ja Lee; Youngmee Jee; Joo-Yeon Lee; Young Ki Choi
Journal:  JCI Insight       Date:  2020-01-30

2.  Association between Severe Fever with Thrombocytopenia Syndrome Incidence and Ambient Temperature.

Authors:  Jimin Sun; Liang Lu; Jun Yang; Keke Liu; Haixia Wu; Qiyong Liu
Journal:  Am J Trop Med Hyg       Date:  2018-03-15       Impact factor: 2.345

3.  Novel SFTSV Phylogeny Reveals New Reassortment Events and Migration Routes.

Authors:  Xiaoli Wu; Mingyue Li; Yanfang Zhang; Boyun Liang; Junming Shi; Yaohui Fang; Zhengyuan Su; Mengmeng Li; Wenjing Zhang; Ling Xu; Jun Wang; Qiaoli Wu; Shuang Tang; Hualin Wang; Tao Zhang; Cheng Peng; Xin Zheng; Fei Deng; Shu Shen
Journal:  Virol Sin       Date:  2020-09-22       Impact factor: 4.327

4.  Investigation of Heartland Virus Disease Throughout the United States, 2013-2017.

Authors:  J Erin Staples; Daniel M Pastula; Amanda J Panella; Ingrid B Rabe; Olga I Kosoy; William L Walker; Jason O Velez; Amy J Lambert; Marc Fischer
Journal:  Open Forum Infect Dis       Date:  2020-04-11       Impact factor: 3.835

5.  Spatial-temporal characteristics of severe fever with thrombocytopenia syndrome and the relationship with meteorological factors from 2011 to 2018 in Zhejiang Province, China.

Authors:  Haocheng Wu; Chen Wu; Qinbao Lu; Zheyuan Ding; Ming Xue; Junfen Lin
Journal:  PLoS Negl Trop Dis       Date:  2020-04-07

6.  Severe Fever with Thrombocytopenia Syndrome Patients with Hemophagocytic Lymphohistiocytosis Retrospectively Identified in Korea, 2008-2013.

Authors:  Kye-Hyung Kim; Myung Jin Lee; Mee Kyung Ko; Eun Yup Lee; Jongyoun Yi
Journal:  J Korean Med Sci       Date:  2018-11-16       Impact factor: 2.153

7.  Alterations of Gut Microbiome in the Patients With Severe Fever With Thrombocytopenia Syndrome.

Authors:  Honghai Xu; Yuanyuan Wei; Hongqiu Ma; Yanyan Liu; Yalong Zhang; Lifen Hu; Jiabin Li
Journal:  Front Microbiol       Date:  2018-10-01       Impact factor: 5.640

8.  Persistence and gender differences in protection against severe fever with thrombocytopaenia syndrome virus with natural infection: a 4-year follow-up and mathematical prediction study.

Authors:  R Qi; Y T Huang; X J Yu
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

9.  Analysis of epidemiological characteristics of four natural-focal diseases in Shandong Province, China in 2009-2017: A descriptive analysis.

Authors:  Rui Chen; Zengqiang Kou; Liuchen Xu; Jie Cao; Ziwei Liu; Xiaojing Wen; Zhiyu Wang; Hongling Wen
Journal:  PLoS One       Date:  2019-08-27       Impact factor: 3.240

10.  An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus.

Authors:  Ki Hyun Kim; Jinhee Kim; Meehyun Ko; June Young Chun; Hyori Kim; Seungtaek Kim; Ji-Young Min; Wan Beom Park; Myoung-Don Oh; Junho Chung
Journal:  PLoS Pathog       Date:  2019-02-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.